DNER and cancer: BET family proteins, in particular, the BRD4, which are important transcriptional and epigenetic regulators, play critical roles during cancer development by modulating chromatin activity to facilitate oncogenic transcription1, thus elicited a great level of interest in developing BET inhibitors (BETi) for cancer treatment2.